4:5 Bonus Shares: Multibagger NSE Stock To Offer 4 Bonus Shares Soon, Falls 5%

Small cap stock, Jeena Sikho Lifecare Ltd declined 4.59% in 1 Week as BSE Sensex fell 825 points and Nifty 50 slipped 260 points amid weak global cues. Jeena Sikho Lifecare shares will go ex-bonus in the ratio of 4:5 on November 2, 2023. The company will issue 4 equity bonus shares to shareholders for every 5 shares held on November 2, 2023. Last trading price of Jeena Sikho Lifecare share on BSE is Rs 1180.00 per share with intraday fall of 2.27%. Jeena Sikho Lifecare shares rallied 680% in last 1-year. Check details below:

Jeena Sikho Lifecare To Go Ex-Bonus On November 2: According to the NSE filing of the company issued on October 16, 2023, "This has reference to the captioned matter, and pursuant to the provisions of Regulation 42 of the SEBI (Listing Obligation of Disclosure Requirement) Regulation, 2015, we wish to inform that JEENA SIKHO LIFECARE LIMITED ("the Company") has fixed Thursday, 2 nd November, 2023, as the Record Date as per below details, to determine eligibility of the shareholders entitled for issuance and allotment of bonus equity shares of the Company, subject to approval of shareholders of the Company in the Extra-Ordinary General Meeting of the Company, scheduled to be held on Monday, 23rd October, 2023."

Jeena Sikho Lifecare Stock Performance, Return In last 5-Years: Last trading price of Jeena Sikho Lifecare share on NSE is Rs 1180.00 per share with intraday dip of 2.27% as on October 23, 2023. The stock's 52-week high price is Rs 1260.00 apiece and 52-week low price is Rs 140.00 apiece, respectively. The company has a market capitalisation of Rs 1591.05 crore. Jeena Sikho Lifecare stock offered return of 90% in last 3-months, jumped 294% in last 6-months, and witnessed a surge of 682% in last 1-year.

About: Jeena Sikho Lifecare came into existence in 2009. Jeena Sikho Lifecare is the leading ayurvedic healthcare system provider in India offering brands such as Shuddhi Ayurveda, Shuddhi Clinics, Origine & HIIMS hospital.

Disclaimer

The stock just highlights the bonus share and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.